Literature DB >> 7991104

Paraneoplastic autoantibodies: the case for a descriptive generic nomenclature.

V A Lennon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7991104     DOI： 10.1212/wnl.44.12.2236

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

Review 1.  Paraneoplastic neurological syndromes associated with Yo, Hu, and Ri autoantibodies.

Authors:  A R Bradwell
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

3.  Lymphoma, paraproteinaemia, and neuropathy.

Authors:  J H Wokke; J H Morris; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

Review 4.  Neurological paraneoplastic syndromes.

Authors:  U Nath; R Grant
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

5.  Immunomodulatory treatment trial for paraneoplastic neurological disorders.

Authors:  Steven Vernino; Brian Patrick O'Neill; Randolph S Marks; Judith R O'Fallon; David W Kimmel
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300

6.  Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes.

Authors:  J Honnorat; J C Antoine; E Derrington; M Aguera; M F Belin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-09       Impact factor: 10.154

7.  Cerebellar degeneration and ocular myasthenia gravis in a patient with recurring ovarian carcinoma.

Authors:  Pietro Caliandro; Marco Luigetti; Enzo Ricci; Massimiliano Mirabella; Pietro Attilio Tonali; Luca Padua
Journal:  Neurol Sci       Date:  2009-10-06       Impact factor: 3.307

8.  Paraneoplastic neurologic syndrome: A practical approach.

Authors:  Sudheeran Kannoth
Journal:  Ann Indian Acad Neurol       Date:  2012-01       Impact factor: 1.383
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.